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Recent studies suggested that trafficking of hematopoietic progenitor cells is related
to cell cycle status. We studied whether adhesion of progenitor cells to extracellular matrix








 cells were stimulated ex vivo for
48 hours with stem cell factor, flt-3 ligand, and thrombopoietin and fractionated by adhesion
to fibronectin or vascular cell adhesion molecule-1 (VCAM-1). Adherent and nonadherent





Binding to fibronectin, but not to VCAM-1, displayed a cell cycle selectivity as the ad-




 cells and in cycling long-term
culture-initiating cells compared to the nonadherent fraction. Combined cell cycle and pheno-











 cells to fibronectin was





preferentially adhered to the VLA-5 binding domain but not to the VLA-4 binding domain of




 cells to fibronectin was a reversible process modulated
by cell cycle progression, because adherent cells could exit the cell cycle and return to a nonad-




The results indicate that the enhanced binding capacity of cycling progenitor cells
to fibronectin is mediated by VLA-5. © 2001 International Society for Experimental
 




During cytokine or chemotherapy-induced mobilization, he-
matopoietic progenitor cell levels increase up to 50-fold in
the peripheral blood (PB). It has been demonstrated that
mobilized cells include stem cells with repopulating ability




cells isolated from mobilized PB compared to bone marrow

















phase of the cell cycle [2]. In particular, primitive long-term
culture-initiating cells (LTC-IC) isolated from PB are quies-
cent, whereas significant numbers of BM LTC-IC are ac-
tively cycling [3]. Furthermore, using DNA/RNA fraction-




 cells are depleted of









The quiescence of PB progenitor cells is not due to the pres-
ence of proliferation inhibitors in the blood [5]. It still is not
known whether mobilization occurs only in noncycling
cells or whether cycling cells are effectively mobilized and
rapidly cleared from the circulation. Most strikingly, en-
graftment of transplanted hematopoietic cells displays a
similar selectivity for quiescent cells. It was first demon-
strated by Ramshaw et al. [6] that murine stem cells ac-
quired an engraftment defect when induced to proliferate by
in vivo 5-fluorouracil treatment. Subsequently, Habibian
and colleagues [7] demonstrated that this negative effect on





of the cell cycle and was reverted after the completion of
mitosis. As for human stem cells, we also observed that cell
cycle progression was associated with a decrease of engraft-
ment capacity in nonobese diabetic/severe combined immu-
nodeficient recipient mice [8]. In light of these findings, it
can be envisioned that both mobilization and engraftment
are regulated by a cell cycle-based mechanism, the exact na-
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ture of which is not known at present. We thus postulated
that the adhesive properties of hematopoietic cells to the
BM stroma were modulated during cell cycle transit.
Within the BM, stem/progenitor cells are located in tight
contact with stromal cells and extracellular matrix (ECM)









1 integrin) was first recognized to mediate in-
teraction between mouse repopulating cells [9] or human
primitive progenitor cells [10] and Fn. More recently, it was









1 integrin) as well [11]. VLA-4 also interacts
with vascular cell adhesion molecule (VCAM)-1 expressed
by stromal cells [12]. It has been reported that the expres-
sion of VLA-4 and VLA-5 by human hematopoietic pro-
genitor cells is modulated during continuous cytokine ex-
posure in ex vivo cultures [13]. However, the relationship
between cell cycle transit and integrin expression and/or func-
tion was not directly established.
In the present study, we investigated whether adhesion of
progenitor cells to defined ECM proteins was dependent on




 cells were in-
duced to cycle in suspension cultures in response to the
combination of stem cell factor (SCF), flt-3 ligand (FL), and
thrombopoietin (TPO), which has been shown to stimulate
the proliferation of primitive progenitor cells [14,15]. We




 cells and LTC-IC
to Fn is enhanced during cell cycle transit, whereas adhe-
sion to VCAM-1 is not modified. Furthermore, our data
show that VLA-5–mediated but not VLA-4–mediated adhe-
sion to Fn is increased during cell cycle transit. Finally, our
results suggest that adhesion of replicating cells to Fn is re-






After obtaining informed consent, mobilized PB samples were ob-
tained from normal adult volunteers according to the guidelines es-
tablished by the Ethical Committee of the University of Liège.
Mobilization was achieved by daily granulocyte colony-stimulat-




g/kg for 5 consecutive





were isolated by immunomagnetic selection using a large-scale
Isolex 300i system (Baxter Healthcare, Newbury, United King-
dom) as per manufacturer’s instructions. Cells were cryopreserved
in small aliquots in 90% fetal calf serum (FCS; Life technologies,
Merelbeke, Belgium) and 10% dimethylsulfoxide (Sigma Chemi-
cal Corp., St. Louis, MO, USA). In some instances, fresh PB sam-
ples were obtained from normal donors providing CD34-selected




cells were purified further using MACS CD34 isolation kits
(Miltenyi Biotech, Auburn, CA, USA). In some experiments, cells
recovered from the Isolex system were labeled with anti–CD34-flu-
orescein isothiocyanate (FITC; Becton Dickinson Immunocytome-
try Systems [BD], San Jose, CA, USA), anti–CD38-phycoerythrin
























 cells were plated in a serum-free medium consisting of Is-




g/mL bovine serum albu-









from Stem Cell Technologies, Vancouver, BC, Canada), 2 mM
alanyl-glutamine, 1% (v/v) lipids cholesterol-rich, 1 mM sodium















 mM 2-mercaptoethanol (all from Biowhit-
taker, Petit-Rechain, Belgium). Cells were stimulated by a combi-
nation of 100 ng/mL SCF (Amgen, Thousand Oaks, CA, USA), 50
ng/mL TPO (Amgen), and 100 ng/mL FL (R&D Systems, Abing-




C in a 100% humidi-









to 96 hours in culture was always greater than 90%.
 


















g/mL solution of Hoechst 33342 (Hst; Molecular Probes, Eu-
gene, OR, USA) in Hst Buffer. Hst buffer consisted of Hank’s bal-
anced salt solution (HBSS; Biowhittaker), 20 mM HEPES (Bio-





for 45 minutes, cells were washed once, resuspended in Hst buffer,
and sorted on a FACS Vantage (BD) equipped with a multiline ul-
traviolet laser (351–364 nm) providing excitation for Hst. Hst sig-








Fn (Sigma) or 40-kDa and 120-kDa Fn fragments (Life Technolo-




C to wells of nontissue culture-treated 24-








 in phosphate-buffered saline (PBS;














to 16 hours. Control plates were coated with 1% BSA (Life Tech-
nologies). The coating solution was removed by aspiration and
plates were incubated with RPMI 1640 (Biowhittaker) containing





C for 30 minutes to block nonspecific binding sites. After two


















C. After 1-hour incubation, nonadherent cells were harvested by
two standardized washes using warm PBS. Adherent cells were
recovered after a 2-minute incubation in an enzyme-free cell dissoci-




C followed by vigorous pipet-
ting. Adherent and nonadherent cells were counted in Fuchs-




L). Percent adhesion was




number of nonadherent cells). Adhesion on BSA-coated control









4 integrin (clone P4C2; Life Tech-










mingen, San Diego, CA, USA) for 30 minutes before the adhesion
assay, as described by Prosper et al. [13].
 
LTC-IC and colony-forming cell assays
 
Absolute frequencies of LTC-IC were determined by limiting dilu-
tion analysis over M2-10B4 fibroblast feeder cells [16] (American
Type Culture Collection Rockville, MD, USA). Briefly, M2-10B4




cells harvested from large-scale cultures in RPMI 1640 with 10%
FCS were irradiated at 7,500 cGy and plated in 96-well plates at




L Myelocult (Stem Cell Technologies).
Within 1 week, human test cells were plated in limiting dilution at














weekly half-medium change. After 5 to 6 weeks, medium was




L of Methocult H4435 (Stem Cell Technologies). After an addi-
tional 2 weeks, wells were scored for the presence or absence of
hematopoietic colonies and the frequency of LTC-IC was calcu-
lated using the maximum likelihood estimator [17]. Colony-form-
ing cells (CFC) were assayed in Methocult H4435 as per manufac-
turer’s instructions.
Cell cycle analysis of LTC-IC was performed by hydroxyurea
(HU; Sigma) suicide assay as described by Cen and Levin [18],
with minor modifications. In preliminary experiments with HU
doses ranging from 0.1 to 10 mg/mL, we established the optimal
dose allowing discrimination between quiescent and cycling pro-
genitor cells, using PB and BM, respectively. At HU concentration

















 4). These data
are consistent with previously published results [19]. In LTC-IC












 cells were treated with 2 mg/





trol cells were incubated in medium only. After two washes in Is-
cove’s medium with 1% BSA, cells were replated in limiting dilu-
tion in LTC-IC assays. The percentage of cycling LTC-IC (% kill)
was estimated using the following calculation: % LTC-IC after
HU treatment/% LTC-IC after incubation in control medium.
 
Flow cytometric analysis of integrin expression
 
FITC-conjugated anti–VLA-4 (CD49d) or anti–VLA-5 (CD49e)
(both from Coulter Immunotech, Marseille, France) were used in





 cells. As more than 90% of either fresh or cultured
cells expressed CD34, anti–CD49e-FITC and anti–CD49d-PE
(Pharmingen) also were analyzed, together without simultaneous
CD34 staining. Cells were incubated with antibodies or isotype-
matched control immunoglobulin G (IgG) for 20 minutes on ice in
the dark. Cells then were washed in PBS 1% calf serum (Biowhit-
taker) and fixed in PBS 1% paraformaldehyde (Sigma). Data were
acquired on a FACSort (BD) flow cytometer and analyzed using
Cellquest software (BD). Positive cells were identified as those
displaying a fluorescence greater than 99% of the isotypic control.
Integrin density was expressed as the mean channel fluorescence
ratio (MCFR) defined as MCF of integrin expression divided by
MCF of fluorescence-matched isotypic control.
 
Flow cytometric analysis of cell cycle status
 
Conventional cell cycle analysis by DNA staining with PI was per-





g/mL PI and 1 mg/mL RNAse (Boehringer, Mann-
heim, Germany). After a 30-minute incubation on ice in the dark,
cells were analyzed on a FACSort flow cytometer using FL-2
channel. The proportion of cells in the different phases of the cell
cycle was determined using ModFit software (Verity Software,
Topsham, ME, USA). Alternatively, cells were analyzed for Ki-67
expression and DNA content as described by Jordan et al. [20],
with minor modifications. Cells were washed and resuspended in 1










 C. Cells then were washed twice in PBS 1% BSA
and stained with FITC-conjugated anti–Ki-67 (clone MIB-1; Coulter




 C. Isotype controls were stained
in parallel. Finally, cells were washed and resuspended in PBS 1%




g/mL 7-aminoactinomycin-D (7-AAD; Sigma).
After a 3-hour incubation on ice, samples were run on a FACSort
flow cytometer using FL-1 and FL-3 channels for Ki-67 and 7-
AAD, respectively.
Combined cell cycle analysis and cell surface staining was per-
formed according to the following procedure. Cells were stained
with FITC-conjugated anti–VLA-5 (CD49e, Coulter Immunotech),
PE-anti–VLA-4 (CD49d, Pharmingen), or nonspecific isotype-




C in the dark. After washing, cells
were fixed and permeabilized with PBS containing 0.5% paraform-




C for 5 minutes. Cells
were washed twice in PBS 1% BSA and stained with PBS 1%




g/mL 7-AAD and 1mg/mL RNAse for 3 hours
on ice. Samples were run on a FACSort flow cytometer. Isotypic








 SEM. Statistical analysis was per-
formed using SigmaStat software (Jandel, San Rafael, CA, USA).









to Fn is increased after ex vivo culture
 
To analyze the consequences of mitotic activation on adhe-





 cells as a “baseline” population of nonadherent and




cells were stimulated in suspension culture for 48 hours in a
serum-free medium supplemented with SCF (100 ng/mL),
TPO (50 ng/mL), and FL (100 ng/mL), a cytokine cocktail
conducive for the onset of primitive progenitor cell replica-































remained constant during culture.
Before and after stimulation, adhesion was determined





C and collecting adherent and nonadherent frac-

















 4). In con-








 3.5% of input for un-

















 0.05). Similarly, adhesion of CFC to Fn









after 48 hours ex vivo.
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Actively cycling CD341 cells
adhere preferentially to Fn but not to VCAM-1
The cell cycle status of PB CD341 cells binding to Fn or
VCAM-1 was assessed by PI staining and FACS analysis,
before and after cytokine stimulation. More than 98% of
freshly isolated PB CD341 cells were blocked in the G0/G1
phase of the cell cycle. There was no difference in cell cycle
status between adherent and nonadherent cells, whether ad-
hesion was assessed on Fn or on VCAM-1 (data not shown).
After 48 hours in culture, 34.3% 6 1.5% of the cells were
engaged in S/G21M (n 5 18). When adherent and nonad-
herent cells to Fn were analyzed separately, the adherent
fraction was enriched in cycling cells: 45.1% 6 3.2% of ad-
herent cells were in S/G21M vs 33.2% 6 2.1% of nonad-
herent cells (n 5 18; p , 0.00001) (Fig. 1). Thus, transit
into the replicative phase of the cell cycle was associated
with increased adhesion to Fn. In contrast, when adhesion
of cultured CD341 cells was assessed on VCAM-1, no asso-
ciation between cycle activation and adhesion was ob-
served. The proportion of cells in S/G21M was similar in
adherent (32.1% 6 3.5%) and nonadherent (32.7% 6 3.3%)
fractions (n 5 6) (Fig. 1).
We next determined the proportion of CD341 cells in G0
in adherent and nonadherent fractions by using high-resolu-
tion cell cycle analysis by Ki-67/7-AAD staining. In this pro-
cedure, a DNA histogram is generated by 7-AAD and plotted
against the expression of the nuclear antigen Ki-67, which is
present in cycling cells but not in G0 cells. To enrich the start-
ing cell population in G0 cells, PB CD341CD38low/2 cells
were isolated (instead of total CD341 cells), cultured for 48
hours in the same conditions, and fractionated by adhesion
to Fn. The proportion of cells remaining in G0 was 15.0% in
adherent cells compared to 24.6% in nonadherent cells, in a
representative experiment (of three) depicted in Figure 2.
Therefore, not only the transit in S/G21M but also the G0–G1
transition was associated with increased cell binding to Fn.
To rule out the possibility that adhesion to Fn by itself
was responsible for the higher cycling status of the adherent
fraction, cultured CD341 cells were first fractionated into
cycling and noncycling cells after staining with Hoechst
33342 (Fig. 3) and then assayed for Fn binding capacity
(Table 1). Adhesion was significantly increased in cycling
cells (25.1% 6 2.6%) compared to noncycling cells (8.0% 6
1.1%, n 5 3; p , 0.05).
LTC-IC are stimulated to
bind to Fn during cell cycle transit
Binding capacity and cell cycle status of primitive progeni-
tor cells were assayed using LTC-IC assays by limiting di-
lution analysis. We first determined the absolute numbers of
LTC-IC at days 0, 2, and 6 of ex vivo culture. We estab-
lished that after 48 hours of suspension culture in SCF, FL,
and TPO, there was an initial 51% 6 22% loss of LTC-IC; 4
days later, LTC-IC numbers had returned to 99% 6 32% of
day 0 levels (n 5 4). This suggests the existence of at least
two subsets of LTC-IC: a first fraction that was not sup-
ported by the ex vivo conditions used (e.g., for lack of a par-
ticular cytokine and/or stromal accessory cells), and another
Figure 1. Binding to Fn, but not to VCAM-1, is increased in cycling cells.
PB CD341 cells were stimulated ex vivo during 48 hours and replated onto
Fn (n 5 18) or VCAM-1 (n 5 6) coated plates and fractionated into adher-
ent and nonadherent fractions. The percentage of cells in S/G21M was
determined by PI staining in total (tot), adherent (Ad), and nonadherent
(Nad) cells. *p , 0.00001 compared to nonadherent cells.
Figure 2. Dual-parameter cell cycle analysis of adherent and nonadherent
CD341 cells to Fn after 48 hours of ex vivo culture. PB CD341CD382
cells were stimulated ex vivo for 48 hours and then allowed to bind to Fn.
The cell cycle status of cells recovered in the adherent and nonadherent
fractions was assessed by simultaneous Ki-67 and 7-AAD staining. The
percentages of cells in G0, G1, and S/G21M are shown in the lower right
quadrant of both panels. A representative experiment is shown.
O. Giet et al./Experimental Hematology 29 (2001) 515–524 519
more responsive subset that eventually provided the recov-
ery of initial LTC-IC numbers after several cell divisions.
Thus, although no LTC-IC expansion could be observed in
these experiments, LTC-IC replication occurred between
days 2 and 6.
Adherent and nonadherent cells to Fn harvested either
from freshly isolated CD341 cells or from cells cultured for
48 hours were replated in LTC-IC assays. In unmanipulated
cells (n 5 4), the frequency of LTC-IC was similar in the
adherent (5.4% 6 1.4%) and the nonadherent fractions
(4.3% 6 1.2%). After 48 hours in culture (n 5 10), the per-
centage of LTC-IC was higher in the adherent fraction
(4.8% 6 0.6%) compared to the nonadherent fraction (2.7% 6
0.4%; p 5 0.0019). LTC-IC assays also were performed af-
ter incubating the cells for 1 hour at 378C on Fn-coated
plates and pooling adherent and nonadherent cells. No dif-
ference in LTC-IC frequency could be demonstrated be-
tween cells exposed to Fn and control cells (data not
shown), indicating that, in our conditions, the increase in
LTC-IC frequency in adherent cells was not the result of a
growth-supporting effect mediated by Fn, as reported else-
where [22,23].
We next examined the cell cycle status of LTC-IC col-
lected in the adherent and nonadherent fractions by suicide
assay. Cells were treated with HU for 1 hour at 378C in or-
der to kill cells during S-phase transit. Control cells were in-
cubated for 1 hour in medium only. Cells then were replated
in limiting dilution in LTC-IC assays and the proportion of
cycling LTC-IC (% kill) determined by calculating the ratio
between the LTC-IC frequency of HU-treated cells and the
LTC-IC frequency of control cells. In freshly isolated PB
CD341 cells, no loss of LTC-IC was observed after HU
treatment, confirming these to be a quiescent population [3]
(Fig 4). After 48 hours in culture, the adherent fraction was
significantly enriched in cycling LTC-IC (% kill 5 58.7% 6
6.7%) compared to the nonadherent fraction (% kill 5
19.7% 6 6.5%, n 5 4; p , 0.05) (Fig. 4). These results in-
dicate that, after a 2-day ex vivo culture, not only was the
adherent cell population enriched in LTC-IC, but, more im-
portantly, the Fn binding capacity of cycling LTC-IC was
higher than that of quiescent LTC-IC.
Enhanced adhesion of replicating
progenitor cells to Fn is mediated by VLA-5
The expression of VLA-4 and VLA-5 integrins at the sur-
face of PB CD341 cells was analyzed before and after 48
hours of cytokine stimulation. The vast majority (99.3% 6
0.5%, n 5 5) of freshly isolated CD341 cells were VLA-41
and after ex vivo culture there was a slight, but not statisti-
cally significant, reduction in VLA-4 expression (93.6% 6
3.6% VLA-41 cells). VLA-4 density, expressed as MCFR,
increased from 14.8 6 2.2 in fresh cells to 30.5 6 10.9 in
cultured cells, but the difference did not reach statistical sig-
nificance (n 5 5; p . 0.05). On the contrary, VLA-5 ex-
pression, which was detectable in only 1.8% 6 2.4% of un-
Figure 3. Cell cycle fractionation by Hoechst staining. Cultured CD341
cells were stained with Hoechst 33342 and fractionated into noncycling
(G0/G1) and cycling (S/G21M) fractions. The purity of sorted cells was
assessed by PI staining of input (A) and sorted cells [(B) noncycling; (C)
cycling]. A representative experiment is shown.
Table 1. Adhesion of FACS-sorted cycling and noncycling CD341 cells
Cell fraction
Experiment no. Total CD341 G0/G1 CD341 S/G21M CD341
1 12.1 6.0 21.1
2 17.3 8.3 24.3
3 14.5 9.7 29.9
Mean 14.6 8.0 25.1*
SEM 1.5 1.1 2.6
Cultured CD341 cells were fractionated into noncycling (G0/G1) and cy-
cling (S/G21M) fractions by Hoechst staining and cell sorting. Adhesion to
fibronectin was measured as described in the Methods section. Data are
from three independent experiments and are given as percent adherent
cells.
*p , 0.05 compared to G0/G1 CD341 and total CD341 cell populations
(one-way ANOVA followed by Student-Newman-Keul’s tests for multiple
pairwise comparisons).
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manipulated CD341 cells, increased after 48 hours of
cytokine stimulation (32.9% 6 2.2% VLA-51 cells, n 5 9;
p , 0.001) (Fig. 5).
We next analyzed in more details whether adhesion of
replicating CD341 cells to Fn was mediated by VLA-4 or
by VLA-5. VLA-4 and VLA-5 expression in cultured CD341
cells was measured separately in G0/G1 and in S/G21M.
VLA-4 was expressed by more than 90% of the cells in either
phase of the cell cycle and with similar density (MCFR 22.9 6
2.7 in noncycling cells vs 23.4 6 4.4 in cycling cells, n 5 3;
p . 0.05). VLA-5 was expressed at higher levels in actively
cycling cells: 59.8% 6 9.6% of CD341 cells in S/G21M
were VLA-51 vs only 23.0 6 5.2% of cells in G0/G1 phase
(n 5 3; p 5 0.02) (Fig. 6). These data document a modula-
tion of VLA-5 expression, but not of VLA-4, by cell cycle
progression.
To test directly VLA-4 and VLA-5 function in stimu-
lated CD341 cells, cells were preincubated with blocking
antibodies against a4 (clone P4C2) or a5 (clone P1D6) in-
tegrins and then assayed for adhesion to Fn. The selectivity
of both blocking antibodies was confirmed with two non-
overlapping Fn fragments. The 40-kDa chymotryptic Fn
fragment contains the CS-1 binding site for VLA-4 but
lacks the RGDS binding sequence for VLA-5 [24]. The
120-kDa Fn fragment contains the RGDS binding site but
Figure 4. Enhanced binding of cycling LTC-IC to Fn. PB CD341 cells
were cultured ex vivo for 48 hours and then replated on Fn-coated dishes.
The cell cycle status of LTC-IC was determined by HU suicide assay in
total CD341 cells before culture (Tot) and in cultured CD341 cells recov-
ered in the adherent (Ad) and in the nonadherent (Nad) fractions to Fn (n 5
4). The percentage of cycling LTC-IC was estimated by the proportion of
LTC-IC killed by HU treatment. *p , 0.05 compared to nonadherent cells.
Figure 5. Changes of VLA-4 and VLA-5 expression in CD341 cells dur-
ing ex vivo culture. VLA-4 and VLA-5 expression was determined in
freshly isolated (0 h) and in cultured (48 h) CD341 cells. The percentage of
cells in each quadrant is indicated. A representative experiment is shown.
Figure 6. VLA-5 expression in cultured CD341 cells is upregulated dur-
ing S/G21M. VLA-5 expression was analyzed in combination with DNA
staining by 7-AAD in cultured CD341 cells. A representative experiment is
shown. (A) DNA histogram showing the distribution of cells in G0/G1
(73.9%) and in S/G21M (26.1%) phases of the cell cycle. (B) Same sample
showing simultaneous staining with control IgG. The horizontal line indi-
cates the limit for nonspecific staining. The vertical line separates cells in
G0/G1 and those in S/G21M. (C) Combined VLA-5 and 7-AAD staining.
The proportion of cells expressing VLA-5 in G0/G1 is 20.5% [15.8/(15.8 1
61.2) 3 100] compared to 55.8% [14.4/(14.4 1 11.4) 3 100] in S/G21M.
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not the CS1 sequence [25]. Anti–VLA-4 blocked CD341
cell binding to the 40-kDa Fn fragment but not to the 120-
kDa Fn fragment, whereas the reverse was observed for
anti–VLA-5 antibody (data not shown). Compared to non-
specific IgG, adhesion of cultured CD341 cells to intact Fn
was predominantly inhibited by anti–VLA-5 and to a lesser
extent by anti–VLA-4 (Fig. 7A), indicating that VLA-4, al-
though present, was not functionally active on a high proportion
(.50%) of the cells. When cells were treated simultaneously
with both anti–a4 and anti–a5, adhesion to Fn was completely
abolished, which excludes the possibility that another receptor
played a significant role in our experimental conditions.
To analyze separately the contribution of VLA-4 and
VLA-5 in mediating adhesion of replicating cells to Fn, cul-
tured CD341 cells were incubated with a blocking antibody
against either a4 or a5. Cells then were allowed to bind to
Fn and the cell cycle status of adherent and nonadherent
cells was assessed by PI staining (n 5 4). When a4 was
blocked, i.e., cells were bound via VLA-5 only, the frequency
of cycling S/G21M cells in the adherent fraction (47.0% 6
3.8%) was similar to that observed after incubation with
mouse IgG (45.9% 6 5.4%; p . 0.05) (Fig. 7B). In contrast,
when a5 was blocked and cells were bound to Fn solely by
VLA-4, there were only 28.7% 6 5.7% cycling cells in the
adherent fraction (p , 0.05 compared to adherent cells after
IgG or anti–a4 treatment) and cycling cells then were pre-
dominantly collected in the nonadherent fraction (Fig. 7B).
Similar results were obtained when the contribution of
VLA-4 and VLA-5 was assessed using Fn fragments.
CD341 cells, either fresh or stimulated for 48 hours, were
allowed to adhere onto plates coated with 40-kDa or 120-
kDa Fn fragments containing the CS-1 and RGDS binding
sites, respectively. Binding of CD341 cells to the 40-kDa
fragment was similar before (6.7% 6 1.1% adherent cells)
and after cytokine stimulation (7.4% 6 1.9% adherent cells;
p . 0.05), whereas adhesion to the 120-kDa Fn fragment
was significantly increased after ex vivo culture, from 3.7% 6
0.8% to 10.4% 6 2.6% adherent cells (p , 0.05) (Fig. 7C).
In addition, cell cycle analysis of adherent and nonadherent
CD341 cells to each fragment revealed that there were more
cycling cells in the adherent fraction to the 120-kDa frag-
ment (50.1% 6 1.7% S/G21M cells) than in the adherent
fraction to the 40-kDa fragment (33.3% 6 0.5% S/G21M
cells; p , 0.05) (Fig. 7D). Taken together with the blocking
antibodies experiments, these data demonstrate that the in-
creased adhesion capacity of cycling CD341 cells to Fn was
primarily mediated by VLA-5.
Fn binding of replicating 
CD341 cells is a reversible process
Finally, we wanted to study whether the increase in VLA-
5–mediated adhesion to Fn in cultured CD341 cells could be
reverted after completion of cell division. To this end, in a
final series of experiments (n 5 5), adherent cells were col-
lected after a 2-day ex vivo culture and transferred to fresh
Figure 7. Enhanced binding of cycling CD341 cells to Fn is mediated by
VLA-5. (A) Cultured CD341 cells were treated with isotype-matched
mouse IgG or with blocking antibodies against VLA-4, VLA-5, or both,
and replated on Fn-coated dishes. The percentage of cells recovered in the
adherent fraction is indicated in each condition (n 5 8). *p , 0.05 com-
pared to mouse IgG. (B) Cultured CD341 cells were treated with isotype-
matched mouse IgG or with blocking antibodies against VLA-4 or VLA-5
and replated onto Fn-coated dishes for 1 hour, after which adherent and
nonadherent cells were harvested. The percentage of cells in S/G21M was
determined in adherent and in nonadherent fractions by PI staining (n 5 4).
#p , 0.05 compared to adherent cells recovered after mouse IgG or anti-
VLA-4 treatment; *p , 0.05 compared to nonadherent cells in the corre-
sponding treatment group. (C) Fresh (0 h) and cultured (48 h) CD341 cells
were plated on the 40-kD or the 120-kD fragment of Fn, containing CS-1
and RGDS sites, respectively. The percentage of adherent cells was mea-
sured in each condition. *Binding to 120-kD Fn increased after culture (p ,
0.05 compared to adhesion at 0 h). (D) Cultured CD341 cells were plated
on the 40-kD or the 120-kD Fn fragment for 1 hour, after which adherent
and nonadherent cells were collected. The percentage of cycling cells was
determined in each fraction. *Percentage of S/G21M cells was higher in
cells binding to the 120-kD fragment compared to cells binding to the 40-
kD Fn fragment (p , 0.05).
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cultures for an additional 48 hours. The percentage of
CD341 cells up to 96 hours in culture was always greater
than 90%. Progeny cells resulting from these secondary cul-
tures again produced an adherent and a nonadherent popula-
tion. Both cell fractions were assayed for cell cycle status.
Most progeny cells (80.6% 6 3.6%) had lost their binding
capacity to Fn. These nonadherent cells were depleted in cy-
cling cells (25.7% 6 3.0% S/G21M cells) compared to the
starting adherent population (39.6% 6 4.1% in S/G21M; p ,
0.05) and compared to cells that were still able to bind to Fn
(34.6% 6 2.6% in S/G21M; p , 0.05). A representative
experiment is depicted in Figure 8. These results suggest
that adhesion of CD341 cells to Fn during ex vivo culture is
transient and reversible after completion of the cell cycle.
Discussion
We examined whether the adhesive properties of progenitor
cells to ECM proteins are modulated by cell cycle transit.
PB CD341 cells were used for these experiments, as they
are blocked in G0/G1 and have very low adhesiveness to Fn
when freshly isolated. After a 2-day ex vivo culture, we ob-
served the appearance of a population of adherent cells to
Fn. In this adherent population, there was a significant en-
richment in cycling (S/G21M) CD341 cells and, more im-
portantly, in cycling primitive progenitor cells assayed as
LTC-IC. Moreover, quiescent CD341 cells remaining in G0
after 48 hours of cytokine stimulation were more frequent in
the nonadherent population. Thus, transition from a resting
state to an activated state in the cell cycle is associated with a
potentiation of adhesion to Fn. Both growth-supporting and
growth-inhibiting effects of Fn have been reported [22,23,26];
thus, it may be argued that Fn binding by itself may alter the
proportion of progenitors in the different phases of cell cycle.
To rule out this possibility, we sorted cycling and noncycling
CD341 cells after ex vivo culture and showed that cycling
cells had a three-fold higher binding capacity as compared
to noncycling cells. This shows unambiguously selective ad-
hesion of cycling cells. However, cell cycle activation does
not directly cause adhesion to Fn, because there also were
many cycling cells in the nonadherent fraction. Still, both cy-
cling CD341 cells and cycling LTC-IC have a higher ten-
dency to bind to Fn than their noncycling counterparts. These
observations are in line with a recent report of Yamaguchi et
al. [27], who described preferential binding of proliferating
CD341 cells to MS-5 stromal layers. Our data further identify
Fn, but not VCAM-1, as a preferential ligand for cycling
cells. We did not observe any quantitative change in adhesion
to VCAM-1 after cytokine stimulation, and binding to
VCAM-1 was not enhanced in cycling CD341 cells. Thus,
enhanced adhesiveness of cycling progenitor cells is restricted
to specific ligands. It remains to be determined whether other
ECM proteins or stromal cell adhesion molecules also are
involved in this cell cycle selectivity.
As for integrin receptors binding to Fn, VLA-4 and VLA-5
were affected differently by cell cycle activation. The pro-
portion of cells expressing VLA-5 was increased during a
2-day ex vivo culture, specifically on the surface of cells
traversing S/G21M. VLA-4 was expressed on the vast ma-
Figure 8. Binding of CD341 cells to Fn during cell cycle transit is revers-
ible. Freshly isolated PB CD341 cells were stimulated ex vivo for 48 hours
and plated over Fn. Adherent (Ad) and nonadherent (Nad) cells were har-
vested separately. Adherent cells were replated in suspension culture for an
additional 48 hours. Cells from these secondary cultures were fractionated
further into adherent and nonadherent cells to Fn. The percentage of S/G21M
cells was determined in each fraction by PI staining. A representative
experiment is shown.
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jority of both unmanipulated and cultured CD341 cells and
with a higher density on cultured cells (although this was
not statistically significant). However, VLA-4 density and
the proportion of VLA-4 expressing cells were not different
in cycling and noncycling cells. Prosper et al. [13] reported
upregulation of VLA-4, but not of VLA-5, at the surface of
PB CD341 cells after a 4-day ex vivo culture. This discrep-
ancy with our results may arise from differences in the cul-
ture conditions used. The cocktail of SCF, FL, and TPO at
high doses used in the present study was selected to induce
maximal proliferation of primitive progenitor cells [14,15].
In contrast, a combination of granulocyte-macrophage col-
ony-stimulating factor (GM-CSF), G-CSF, SCF, leukemia
inhibitory factor, macrophage inhibitory protein-1a, and in-
terleukin-6 at low doses was used in the study by Prosper et
al. to promote the survival of progenitor cells with minimal
proliferation. Therefore, it should not be surprising that the
increase of VLA-5–mediated adhesion to Fn was not ob-
served by Prosper et al., because it occurs mainly in cycling
progenitor cells. A formal comparison of integrin changes
after progenitor cell stimulation with physiologic or phar-
macologic cytokine doses should be undertaken to provide
further support for this interpretation.
There has been controversies in the literature as to the
extent of VLA-4 expression on PB CD341 cells. In several
reports, VLA-4 was found on a smaller proportion of PB
CD341 cells as compared to BM [13,28], whereas in other
studies [27,29], including our own, it was reported that
VLA-4 was expressed on the vast majority of PB CD341
cells. These discrepancies are likely due to the fact that
VLA-4 expression is quite homogeneous, with no clear sep-
aration between negative and positive cells. Depending on
the sensitivity of the method and/or the equipment used, PB
CD341 cells labeled with anti–VLA-4 may or may not
overlap with isotypic controls, whereas BM CD341 cells
are brightly positive. Lichterfeld et al. [29] reported that
VLA-4 is expressed by the majority of PB CD341 cells but
at a lower density (or MCFR) than in BM CD341 cells.
VLA-4 and VLA-5–mediated adhesion to Fn was func-
tionally assessed by blocking antibodies. When a4 integrin
was blocked, there was a 50% reduction in adhesion of cul-
tured CD341 cells compared to nonspecific IgG, indicating
that although expressed on more than 90% of the cells,
VLA-4 was not fully active. In that case, binding to Fn oc-
curred via VLA-5 only and was still increased in cycling
cells. When a5 integrin was blocked, adhesion to Fn was re-
duced by approximately 80%, demonstrating a predominant
role of VLA-5 in Fn binding of cultured CD341 cells. Most
importantly, cycling cells were less able to attach to Fn and
then were predominantly collected in the nonadherent frac-
tion. These data demonstrate that the preferential binding of
cycling CD341 cells to Fn is more specifically mediated by
VLA-5. This was further shown by using Fn fragments. Fol-
lowing cytokine stimulation, adhesion of CD341 cells
was increased on the 120-kDa Fn fragment recognized by
VLA-5 but not on the 40-kDa fragment recognized by
VLA-4. In addition, binding to the 120-kDa Fn fragment
was increased in cycling cells compared to noncycling cells,
whereas adhesion to the 40-kDa Fn fragment was not.
VLA-4 and VLA-5 are expressed by resting progenitor
cells in a low-affinity state providing weak interaction with
Fn. Cytokines such as interleukin-3, GM-CSF, SCF, and
TPO [30–33] increase transiently the affinity of VLA-4 and
VLA-5 for Fn without concomitant changes in the expres-
sion of these receptors. In this study, we show that, in addi-
tion to the regulation of integrin affinity, cytokine stimula-
tion allows overexpression of activated VLA-5 once the
cells are engaged in cell replication. Therefore, we propose
that fast changes in the affinity of integrin receptors occur
independently of cell cycle status, whereas slower modula-
tion of integrin expression (particularly of VLA-5) takes
place during cell proliferation.
Many reports suggest that trafficking of hematopoietic
stem cells in and out of the BM is modulated by cell cycle
status. First, only resting progenitor cells are found in PB
[2,5]. Our results support the hypothesis that the absence of
cycling hematopoietic cells in PB may result from their se-
lective retention in the BM stroma or from their selective
uptake in extramedullary tissues onto Fn-coated sites. Sec-
ond, engraftment of transplanted cells is impaired during
cell replication [7,8,34]. When viewed in the context of ex
vivo expansion and gene therapy, our results show that after
48 hours of culture in conditions promoting stem cell prolif-
eration, adhesion of replicating cells to Fn is significantly
augmented. Whether enhanced VLA-5–mediated adhesion
to Fn could possibly modify migration and/or homing and
engraftment of cultured cells remains to be tested in vivo.
Interestingly, several reports now have established a recip-
rocal relationship between adhesion and migration. When
adhesion is maximal, the cell is immobilized and cannot
migrate, whereas at intermediate adhesiveness, dynamic
disruption of cell–substratum interactions may allow cell lo-
comotion [35,36]. If the same applies to primitive hemato-
poietic cells, higher expression of VLA-5 during cell repli-
cation in ex vivo conditions subsequently may limit the
intramedullary migrating ability and hence the capacity to
lodge to specific niches in the BM microenvironment.
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